Abstract
Malaria continues to be among the most lethal infectious diseases. Immediate barriers include the detection of low-parasitemia levels in asymptomatic individuals, which act as a reservoir for future infections, and the emergence of multidrug-resistant strains in malaria-endemic, under-resourced regions. The development of technologies for field-deployable devices for early detection and targeted drugs/vaccines is an ongoing challenge. In this respect, the identification of hemozoin during the Plasmodium growth cycle presents a unique opportunity as a biomarker for malaria infection. The last decade has witnessed the development of numerous opto-/magnetic- based ultrasensitive hemozoin sensing technologies with tremendous potential of rapid and accurate malaria diagnosis and drug testing. The unique information in hemozoin formation can also shed light on the development of targeted drugs. Here, we present a comprehensive perspective on state-of-the-art hemozoin-based methodologies for detecting and studying malaria. We discuss the challenges (and opportunities) to expedite the translation of the technology as a point-of-site tool to assist in the global eradication of malaria infection.
Similar content being viewed by others
Introduction
Malaria is one of the most lethal and prevalent infectious diseases, which continues to cause the deaths of around half a million people each year.1 To achieve the fast-approaching United Nations Sustainable Development Goal of global malaria elimination by 2030,2 two processes i.e., accurate (specific and quantitative) diagnosis and appropriate (targeted drug) treatment, are crucial. Low-density malaria parasitemia in asymptomatic individuals at the early stage of infection goes undiagnosed or unnoticed, which serves as a reservoir for future infections and hinders the breaking of disease transmission. Nevertheless, the past two decades have witnessed unprecedented success in reducing the mortality rate. These efforts, however, were hampered by the growing parasites’ resistance strains to common anti-malarial drugs in endemic, under-resourced regions.1,3 Additionally, the global spread of the COVID-19 pandemic in early 2020 jammed the healthcare system, putting a soft halt in the fight against malaria. In a likely reflection of this, devastating numbers of malaria deaths have been reported in 2020,4 and the first malaria vaccine, despite its modest efficacy, was approved by the World Health Organization in 2021.4,5 While malaria has always been prevalent in tropical and sub-tropical regions (e.g., sub-Saharan Africa), the increasing human mobility (e.g., travel and migration) poses a threat of malaria resurgence in traditionally non-endemic areas (e.g., United States and Europe).6 Altogether, it is essential to take proactive measures to avoid being caught off-guard in any unforeseen upsurge of malaria, considering that the threat posed by COVID-19 still persists. This preparedness is especially crucial for remote, low-resource settings where malaria is already endemic.7,8
The ability of rapid and accurate diagnosis at the level to detect asymptomatic carriers, ideally <0.0001% parasitemia (≈5 parasites/µL of blood), will significantly impact disease transmission dynamics, and therefore, have a positive impact on the malaria elimination program.9 The gold standard in malaria diagnosis, microscopic examination of Giemsa-stained infected red blood cells (i-RBCs) on a glass slide, remains unchanged for over a hundred years. Although the methodology is low-cost, quantitative, and parasite-specific, it is labor-intensive and time-consuming (around 1 h), and an average microscopist can only detect 0.001% parasitemia. Therefore, the search for detection methods at the sub-microscopic level with a speedy result remains a topic of high significance in malaria research.
Other clinically employed and emerging diagnostic technologies can be broadly categorized based on the target molecule, such as organic (e.g., protein and DNA/RNA) and inorganic (e.g., hemozoin). The methodologies adopted for the former are further classified into molecular-based techniques e.g., polymerase chain reaction (PCR), and serological-based techniques e.g., rapid diagnostic test (RDT).10 PCR-based methods offer highly reliable and sensitive detection of < 0.0001% parasitemia, but are extremely slow to assess (at least in 2 h), costly, and require laboratory infrastructure, limiting their practicality for on-site application or limited medical-resources settings in under-developed or developing countries. Toward this end, low-cost and easy-to-use RDTs, based on lateral-flow immunoassay of parasite-specific antigens (e.g., HRPII and pLDH), offer moderately speedy malaria detection in less than 20 min, but the method lacks high accuracy (specificity) and does not even have the same level of sensitivity as light microscopy. Moreover, false positives due to the persistence of antigens for an extended period (after the infection has been cleared), false negatives, and no species identification (in the absence of HRPII), along with an inability for quantitative analysis, limit the performance and derived information from RDTs. Finally, RDTs generally require refrigeration, which is not suited for deployment in remote, under-resourced regions. Details and recent developments in these methodologies are discussed elsewhere.10,11,12,13
Individually, the current diagnostic tests (e.g., light microscopy, molecular approaches, serological tests, and RDTs) are not perfect for rapid (within a few minutes) and highly specific diagnoses at low (<0.0001%) parasitemia levels to detect asymptomatic carriers [see Table 1 and Fig. 1]. To this end, the scientific community in malaria research has paid great attention to interdisciplinary research on cutting-edge technologies focusing on inorganic malaria pigment, hemozoin,14 which also provides a wide variety of information not available in traditional methods. Hemozoin, formed in an intra-erythrocyte cycle of the malaria parasite, is rich in magnetic and optical properties. Based on these characteristics, the identification of hemozoin presents a unique opportunity for malaria diagnosis and also provides the ability to analyze hemozoin formation, which may play a vital role in the testing and discovery of new targeted antimalarial drugs.
In the past decade, numerous hemozoin sensing technologies have been developed and refined for nearly ideal diagnostic characteristics, including ultra-sensitivity, high specificity, rapid result, and cost-effectiveness. Some of these technologies have already been tested in animal studies and in the field. Additionally, hemozoin-based sensing has been realized with microdevices, particularly lab-on-a-chip for point-of-care diagnostics, and can also offer noninvasive diagnostics, as reviewed elsewhere.15,16,17,18,19 Furthermore, expert reviews on magnetophoretic20 and optical methods21,22,23 have been added to the literature at different times. Nonetheless, there remain plenty of fundamental questions to address (e.g., background signals from whole blood24), and further developments (e.g., machine learning) are still needed to facilitate easier decision-making for a more specific malaria diagnosis. At the bottom, the underlying mechanism for hemozoin formation is still not entirely clear, which is particularly important for the development of new targeted drugs.
We identified underlying questions and shed light on possible actions to develop an optimal malaria diagnostic tool and targeted antimalarial drugs, thereby advancing hemozoin-based technologies to a clinical platform. The article is structured to emphasize each aspect of hemozoin, ranging from its fundamental structure to its use in technology for global malaria elimination. Section “Biochemistry of malaria: hemozoin nanocrystals” covers the formation of hemozoin in the intra-erythrocyte cycle and recent progress in imaging the underlying mechanisms to assist in the development of new targeted drugs. Section “Magnetism of hemozoin: a double-edged sword” explores the magnetism of solitary hemozoin and its enigmatic nature (paramagnetic or superparamagnetic), as well as the resultant changes in magnetic characteristics from healthy to malaria-infected blood. In Section “Hemozoin sensing technologies”, we introduce hemozoin sensing technologies, encompassing “Magnetic-based technology” and “Optical-based technology”, and advanced methods based on the “Magneto-Optical based technology” optical detection of the magnetic fingerprints of hemozoin. We provide an up-to-date review of the various successes achieved using these different modalities. Section “Field evaluation” compares the performance of hemozoin detection technologies, specifically in field testing, with existing clinical methods serving as reference standards. In Section “Outlook”, we present our perspective on challenges with hemozoin-based diagnostics and outline future directions to expedite the translation of these technologies into actual field implementation. Section “Concluding remarks” will offer concluding remarks on the current status of this research field.
Biochemistry of malaria: hemozoin nanocrystals
Malaria is a mosquito-borne disease caused by parasites of the genus Plasmodium,25,26 which proliferate in an intra-erythrocytic (asexual) cycle from the ring stage to trophozoite and eventually to the replicating schizont stage (and so on) [see Fig. 2]. In an acidic lysosome-like organelle, known as the food or digestive vacuole (DV), the parasites cause proteolysis of erythrocytic hemoglobin (Hb)27,28 as a principal nutrient source, releasing Fe2+-centered heme,29 which instantaneously oxidizes to by-product Fe3+-containing (free) heme. To mitigate the high cytotoxicity of free heme, the parasites convert it into a physiologically insoluble product called hemozoin.30 Thus, hemozoin formation is a vital process for the survival of Plasmodium parasites, and the underlying mechanism is crucial to understanding the modes of action of antimalarial drugs and searching for new possibilities.31,32,33
Hemozoin was long considered to be a linear coordination polymer34,35 of (oxidized) heme molecules. However, the X-ray diffraction study36 confirmed its crystalline nature with triclinic symmetry, resulting from cyclic dimerization of porphyrin rings via iron carboxylate links, followed by the intra-molecular hydrogen bonding to form a crystal [see Fig. 2]. The low crystal (triclinic) symmetry favors unidirectional growth [along (100) axis], giving rise to a high aspect ratio parallelogram or needle-like shape with a long-axis dimension in the sub-micrometer range. The crystal morphology changes moderately for different Plasmodium species and developmental stages.37 However, the mechanisms governing hemozoin nucleation and growth remain enigmatic. Initially, the hemozoin crystal nucleation mechanism was suggested to be nonenzymatic and autocatalytic (physicochemical),38,39 with crystal growth occurring over “preformed” β-hematin (consisting of one unit of hydrogen-bonded heme molecules). Soon, several in vitro studies highlighted the involvement of neutral lipids in hemozoin formation. These studies suggested hemozoin nucleation and growth within neutral lipid nanospheres in DV,40 acylglycerol suspensions,41 and acylglycerol lipid-solution interfaces.42,43 Another study44 hypothesized the existence of double-membrane hemoglobin transport vesicles (HTVs), consisting of the outer parasitophorous vacuole (PV) and the inner parasite plasma membrane (PPM). Hemoglobin digestion occurs inside the PPM, while heme biomineralization takes place on the surface. These HTVs eventually fuse with the DV.
Two pioneering reports by Kapishnikov et al.45,46 clarified the nature of the growth medium. The first study using nanoprobe beam X-ray Fe-fluorescence and diffraction45 revealed a clustering of hemozoin crystals with parallel alignment (of needle c-axes) such that (100) crystal faces were exposed to a curved surface. This suggests hemozoin nucleation via a common template and thus, excludes the process within lipid droplets. The companion study, employing high-contrast cryo soft X-ray tomography (cryo-XT) and electron microscopy,46 addressed the questions related to the curved surface and HTVs hypothesis. The study confirmed the DV inner membrane as the common template for (100) oriented hemozoin nucleation. While the study also observed HTVs as uniform dark spheres, no hemozoin crystals were detected within the HTVs or along their pathway to the DV [see Fig. 2]. Additionally, the authors investigated the chemical environment of hemozoin crystallization and found it to occur in an aqueous milieu without any signature of lipid droplets enclosing the hemozoin crystals. This is further confirmed in their recent study with cryo-scanning transmission electron tomography in situ.47
Moreover, several parasite proteins, such as heme detoxification protein (HDP),48 and its association with falcipain 2 (a major hemoglobinase) in a multiprotein complex in Plasmodium falciparum,49 are shown to be extremely potent for hemoglobin degradation and hemozoin formation processes. Another important Plasmodium parasite-secreted protein is lipocalin-like PV5, which plays a crucial role in the development of asexual blood-stages in malaria.50 A recent in vivo electron microscopy study51 further demonstrated the significance of PV5 in the degree of heme biomineralization and, more importantly, in the regulation of hemozoin crystal unidirectionality. In Plasmodium berghei (in mice), PV5 transcriptional deregulation reduces hemozoin production, but this also causes an excessive elongation of hemozoin crystals. Conversely, its inactivation in P. falciparum results in the formation of hemozoin crystals with multidirectional branching. This study also supports the picture of hemozoin crystallization occurring within the aqueous milieu of the parasite’s DV. Regardless of considerable changes in crystal morphology when PV5 is perturbed, electron diffraction experiments reveal an unaltered crystalline property, thus excluding a significant role of PV5 in hemozoin nucleation. Therefore, future studies are needed to understand hemozoin formation clearly to expedite the targeted drug development efforts.
Magnetism of hemozoin: a double-edged sword
Iron (Fe) is one of the few elements that possess ferromagnetic (FM) properties at room temperature. Given the rich elemental content of Fe in hemoglobin in RBCs, magnetic techniques have become an apparent choice for studying blood. In a seminal work in the 1930s on magnetism in blood, Pauling and Coryell52,53 found Fe2+ (low-spin S = 0, diamagnetic) in oxyhemoglobin (oxy-Hb), Fe2+ (high-spin S = 2, paramagnetic) in deoxyhemoglobin (deoxy-Hb), whereas Fe3+ (high-spin S = 5/2, paramagnetic) in methemoglobin (met-Hb). In 1964, Weiss hypothesized that deoxyHb withdraws an electron from the Fe2+ ion resulting in a low-spin Fe3+ (S = 1/2) state, and the oxygen is converted to superoxide O2− (S = 1/2), which is then taken into anti-ferromagnetic (AFM) exchange interaction.54 Since healthy RBCs (h-RBCs) are primarily composed of oxyHb and contain a small amount of deoxy-Hb, healthy blood, also containing other diamagnetic components (water, white blood cells, etc.), collectively exhibits a negligibly weak diamagnetic/paramagnetic response (depending on the oxygenation).55,56 Nevertheless, a measurable change in oxygen binding in many diseases like malaria,55,57,58 diabetes mellitus,59 methemoglobinemia,60,61 sickle cell disease,62 etc. results in a detectable change in the magnetic characteristics of human blood.
In 1946, M. Heidelberger and co-workers63 used permanent magnets to separate malaria i-RBCs from blood plasma. This method relies on the magnetism of the malaria byproduct, hemozoin with Fe3+ (high-spin S = 5/2, paramagnetic) ions, as confirmed through electron spin resonance (ESR) and Mössbauer spectroscopy.64,65 The efficiency of separating i-RBCs is further improved by the use of gradient magnetic fields,66,67,68 known as magnetophoresis, and improvement in microfluidic channels [see Fig. 3 for example].20,69,70 The analysis of field-induced cell transport, termed magnetophoresis mobility (M.M.),71 provides a quantification of the relative (w.r.t. medium) magnetic susceptibility (∆χV = χsample − χmedium) of live erythrocytes. This method revealed a negative ∆χV (diamagnetic) for oxy-Hb, while a positive ∆χV (paramagnetic) for deoxy-Hb and met-Hb71 [see Table 2], thereby confirming the observations made by Pauling and Coryell.52,53 The M.M. methodology has also demonstrated a graduated increase in ∆χV for i-RBCs in malaria-developmental stages, with an increase in the hemoglobin-to-hemozoin conversion factor of up to 50% or more in the mature (schizont) stage.57 The ∆χV obtained from the M.M. method is validated by the bulk magnetometry method, which measures field-dependent magnetization (M-vs-H) for separated i-RBCs, as conducted by Hackett et al.55 This study also examined isolated hemozoin crystals and obtained two orders of magnitude higher χV, which corresponds to an effective magnetic moment, µeff = 5.1 µB/Fe, associated with high-spin Fe3+ (high-spin S = 5/2) in hemozoin.
To gain further insights into the magnetism of solitary hemozoin, its structural analog, lab-grown β-hematin nanocrystals72,73 were investigated. In 2013, Butykai et al.74 conducted a magnetometry study on randomly oriented crystals (in powder form) and magnetically aligned crystals in liquid suspensions (achieved through a freezing process in the presence of a magnetic field). They observed a significant difference in magnetization along the plane of the porphyrin rings (referred to as the magnetic easy-plane, Mx) and its perpendicular C4v rotation axis (referred to as the magnetic hard axis, Mz) with a ratio of Mx/Mz ≈ 9.6 (at 2 K). This ratio decreased with increasing temperature but remained noteworthy at Mx/Mz ≈ 1.16 at room temperature. These findings were consistent with an earlier multi-frequency high-field ESR study65 on both hemozoin and β-hematin at cryogenic temperature (10 K). The ESR study used a spin Hamiltonian model with nearly axial symmetry, represented as H = µBgS.B + D[Sz2 − S(S + 1)/3] + E(Sx2 − Sy2), which revealed a dominance of zero-field splitting (D) term associated with an axial anisotropy, with a negligible contribution from E-term, accounting distortion in C4v symmetry (in porphyrin ring), as | E/D | = 0.035. The magnetic field-induced Zeeman-splitting yielded an almost isotropic g-factor ≈2. This ESR study,65 supported by the findings of magnetometry study by Butykai et al.,74 suggests hemozoin is a highly anisotropic easy-plane paramagnet.75
Though Butykai et al.74 observed a linear M-vs-H (paramagnetic) behavior at room temperature, the low-temperature spectra obtained at 2 K, also measured by Gossuin et al.,76 displayed a non-linear behavior with technical saturation, a characteristic associated with cooperative spin ordering, as in FM materials. In a big surprise, Inyushin et al. obtained a nearly saturated M-vs-H loop at room temperature, which exhibited zero remanence and coercivity, suggesting hemozoin is a superparamagnet (SPM). This observation is well supported by their theoretical ab initio calculations. SPM property is further validated by a significantly high magnetic susceptibility, χV ≃3842, which is orders of magnitude greater than χV values reported in other studies on both natural and synthetic hemozoin [see Table 2]. Subsequently, Giacometti et al.77 conducted a magnetometry study on β-hematin crystals obtained from the same manufacturer as those used by Inyushin et al.78 This study observed a linear M-vs-H response under similar field conditions, indicative of a paramagnetic character at room temperature. In a nutshell, M.M. experiments57,79 conducted on malaria-infected blood in a fixed applied magnetic field gives a susceptibility of the order of 10−6 [see Table 2], which falls within the range (usually <10−3) associated with paramagnets. However, the typical confirmation of a paramagnet is a linear field-dependent magnetization, observed up to magnetic fields of a few tenths of Tesla. The majority of magnetometry studies put forward a paramagnetic behavior at room temperature,55,74,76,77 with one notable exception showing SPM characteristics.78 The significant distinction between the two scenarios lies in the notably smaller long axis of β-hematin crystals that exhibit SPM behavior [see Table 2]. Indeed, SPM is a property associated with finite-size effects [see Fig. 3], a phenomenon encountered in widely studied magnetic nanomaterials.80,81
The bulk (superconducting quantum interference and vibrating sample) magnetometry55,74,76,77 and magnetophoresis mobility57,79 experiments measure the (collective) magnetic susceptibility of hemozoin ensembles, encompassing a sizeable range of nanocrystal dimensions. This distribution in crystal size may play an important role in the magnetic ground state of hemozoin. To resolve this issue, magnetically-active optical defects, e.g., Nitrogen-Vacancy (NV) centers in diamond,82,83,84 offer high sensitivity at a nanoscale spatial resolution to individually identify FM and SPM particles.85,86 Fescenko et al.87 employed an NV-based diamond quantum sensor to measure the stray magnetic fields produced by individual hemozoin crystals when subjected to external magnetic fields [see Fig. 4]. This study revealed a paramagnetic response with χV ≃340 × 10−6, consistent with the findings from the bulk magnetometry study,55 for over 95% nanocrystals (with a long axis >200 nm). On the contrary, the smaller nanocrystals exhibited higher magnetization, following a Langevin field dependence, characteristic of SPM behavior, thus supporting the bulk magnetometry study on β-hematin crystals conducted by Inyushin et al.78 It is worth noting that, as crystal size increases, a transition from SPM to FM regime is commonly observed in magnetic nanomaterials80,81 [see Fig. 3]. Nevertheless, NV-ODMR imaging of individual hemozoin crystals highlights the crucial role of crystal morphology in determining the magnetic properties of hemozoin. The origin of this peculiar SPM nature/impurity in smaller nanocrystals holds significance in understanding the hemozoin formation in the early ring stage of malaria.
Hemozoin sensing technologies
Magnetic-based technology
The magnetism in malaria-infected erythrocytes, associated with hemozoin, is firstly employed in the magnetophoretic method, as discussed in Section “Magnetism of hemozoin: a double-edged sword”, which serves as an effective tool for magnetic characterization of biological fluids. Jeonghun Nam et al.70 successfully separated i-RBCs from h-RBCs through microfluidic channels, achieving a recovery of 73% for early-stage (ring) i-RBCs and over 98% for late-stage (trophozoites and schizonts) [see Fig. 3]. This approach has also offered an initial step in concentrating i-RBCs for improved diagnostic performance using existing methodologies.88,89 Conventional light microscopy is limited due to the time-consuming nature of optical scanning, which involves visually scanning the entire slide. However, magnetic enrichment, as seen in magnetic deposition microscopy,88 enhances the ability to visualize i-RBCs at specific positions, making staining and scanning more efficient and reducing the time required for diagnostics. This approach has been demonstrated for all the human malaria parasite species, with at least a 40-fold enrichment for P. falciparum and up to a 375-fold enrichment for Plasmodium ovale infections, significantly enhancing sensitivity compared to conventional light microscopy. Furthermore, a microfluidic device, incorporating coupled magnetic beads (for capturing i-RBCs) and quantum dot-antibodies conjugates (for detecting P. falciparum secreted HRPII), has been reported.89 This device enables quantitative immunoassay assessment with at least a 10-fold increase in sensitivity compared to traditional RDTs. Therefore, magnetic enrichment offers new possibilities for enhancing existing clinical malaria diagnostic methods.
The idea of magnetism in hemozoin in recent history was examined in nuclear magnetic resonance (NMR) relaxometry studies.17,90,91 The relatively large magnetic susceptibility of these hemozoin crystals induces substantial changes in the transverse relaxation rate of proton NMR in RBCs to infer the ‘parasite load’ in blood. This idea was initially reported by Karl et al.92 The team, however, concluded that NMR relaxometry (using unprocessed raw blood) was unlikely to have enough sensitivity for malaria diagnosis in the field setting. Weng Kung Peng and co-workers58,93,94 demonstrated that it was possible to have an ultrasensitive malaria diagnosis by increasing the filling factor of the probe and introducing a vital enrichment step to separate the i-RBCs from h-RBCs via hematocrit centrifugation. This breakthrough was observed with a portable benchtop micro-NMR system utilizing an ultra-short echo technique (UET) [see Fig. 5a–c] in their in vitro cultured P. falciparum parasites as well as in vivo mice studies, demonstrating rapid (less than 5 min) and ultrasensitive detection (<10 parasites/µL) for the early-stage malaria infections. The minimal sample processing steps (without any chemical or immunolabeling) reduce human-induced errors for measurements in the field setting. Subsequent to this development, several similar works were reported,95 introducing new functionalities to enhance i-RBCs separation (using microfluidic margination96 and lysis control97). NMR relaxometry has also been employed for drug studies.98
The process of hemozoin formation is mediated heavily by the transfer of an electron. The use of higher dimensional NMR or ESR spectroscopy (or a combination of them)99 should have the capability to differentiate the detailed structure of hemozoin, enabling the identification of Plasmodium species. In a related development, in 2020, Weng Kung and his team59 demonstrated the use of (pseudo) two-dimensionality (2D) in the time-domain NMR to obtain highly specific and unique molecular fingerprinting of various redox (and hence oxidative/nitrosative) states of hemoglobin from a single drop of blood [see Fig. 5d–g]. This T1–T2 relaxometry approach (termed as ‘Clustering NMR’100) may be extremely useful for rapid and accurate object classification using a low-field micro-NMR system. This new methodology is demonstrated in the clinical point-of-care diagnosis of diabetes based on the oxidative status of blood.59
Another way of recording weak magnetic fields is based on spintronics, utilizing the spin-related magnetoresistance effect, which is the tendency of a material (often ferromagnetic) to change its electrical resistance as a function of the magnitude and direction of the applied magnetic field. This phenomenon has led to the development of giant magnetoresistance (GMR) and tunneling magnetoresistance (TMR) sensors, borrowed from advanced technology in hard disc drives and high-density magnetic memory. Now, it is tackling the next generation of ultrasensitive magnetic sensors for detecting low pico-Tesla level magnetic fields. Recently, Heidari and his team101 demonstrated a proof-of-principle for a miniaturized, low noise, low power, and highly sensitive TMR sensor using a CMOS analog front-end readout circuit for the detection of paramagnetic hemozoin nanocrystals [see Fig. 6a–e]. The team has developed the first miniaturized and handheld TMR-based device with the following components: a sensor, a handheld permanent magnet for magnetizing of the hemozoin crystallites, and an analog front-end circuitry for signal amplification and noise cancelation, which can all be integrated into an easily portable compact and cost-effective design. This magnetic-based lab-on-chip platform potentially offers a rapid and easy-to-use malaria diagnostic method without direct contact of blood samples via excellent compatibility with electronic devices.
Towards another lab-on-chip diagnostic technology, R. Bertacco and co-workers79,102 have developed a microchip-based diagnostic tool, namely TMek, which relies on the magnetophoretic separation of magnetic malaria corpuscles, and the measurement of impedance variation caused by these corpuscules [see Fig. 6f–h]. The team utilized micro magnetic concentrators to create a high magnetic field gradient, effectively competing with gravity to separate i-RBCs (containing hemozoin crystals) at localized sites within a silicon microchip (for a fixed capture time), where a highly sensitive electrical detection is performed. Upon taking magnets away (release phase), the amplitude of variation in the signal provides a quantification of the parasitemia level. Additionally, the time evolution of the electrical signal (waveform) exhibits distinctive patterns corresponding to different malaria infection stages. This single microchip, without the need for active microfluidics, can quantify parasitemia at concentrations as low as 10 parasites/µL, offering the potential for a stage-selective malaria diagnosis.
Optical-based technology
Alongside its peculiar magnetic properties, hemozoin exhibits rich optical characteristics, including high optical absorbance,103 birefringence,104 and nonlinear dielectric susceptibility,105 among others, which provide opportunities for optical quantification of malaria parasites.
In a straightforward approach, light absorbance was measured in vivo in a mice study;106 however, the sensitivity (>0.03%) is insignificant for early diagnosis. More recently, Susana O. Catarino and co-workers exploited optical spectrophotometry in both absorbance103 and reflectance107 modes. In the absorbance mode, the team successfully detected synthetic hemozoin in healthy blood down to a limit of 1 µg/mL with high specificity, while in reflectance mode, they achieved the detection of P. falciparum parasites at concentrations as low as 12 parasites/µL, using thin-film optical filters.
The birefringent property of hemozoin, which induces depolarization of light at 90° relative to the laser, was harnessed through polarization microscopy104 within the sensitivity range of light microscopy. Hemozoin birefringence has also been employed in automated flow cytometry, with commercial Cell-Dyn analyzers.108 However, the high cost and the bulky setups limit their widespread use in resource-poor settings.109 The integration of photoacoustics into flow cytometry allows for in vivo ultrasensitivity of 0.005 parasites/µL,110 but this requires a high dilution (to the extent of one cell under laser irradiation) and, consequently, long processing times (in hours). This processing time is significantly reduced to just a few minutes with the use of a surface-acoustic-wave (SAW) sensor.111,112 However, this approach is currently demonstrated for a limited sensitivity of ring-stage 0.5% parasitemia in the whole blood. The team intends to increase the sensitivity by integrating this SAW sensor into a proposed optoacoustic microfluidic device.113 Moreover, Pourabed et al.114 have recently developed an acoustically actuated microfluidic mixer for enhancing whole blood lysis in just 2 s. This platform, when combined with a spectroscopic approach, holds the potential for rapid malaria diagnostics using whole blood samples.
The optical properties of hemozoin have also been explored under the action of ultrashort near-infrared (NIR) laser pulses, leading to the formation of transient vapor nanobubbles around hemozoin115 and efficient third-harmonic generation (THG).105,116 These hemozoin-induced vapor nanobubbles (H-VNBs) were detected using a photoacoustic probe in a mice study down to 0.0034% (≃17 parasites/µL) in seconds in a non-invasive manner. In human blood, detection has been extended to even lower parasitemia levels, reaching 0.0001% (≃5 parasites/µL). On the other hand, THG imaging of hemozoin105,117 in a scanning cytometry approach116 can provide single-cell characterization in an automated and rapid scanning process that takes just a few minutes. This methodology was validated with blood samples obtained from malaria patients with parasitemia levels of 0.2% or higher, showing close consistency with light microscopy results. Although the two methods offer highly sensitive and rapid diagnostics, the initial requirement of expensive ultrashort laser sources presents a challenge for clinical diagnostics.
Vibrational (Raman and infrared) spectroscopy techniques [see Fig. 7] have emerged as powerful tools for extracting biochemical information and enabling low-cost clinical diagnostics for various diseases, including malaria.22 Raman spectroscopy measures the characteristic (emitted) light wavelength from inelastic scattering by the hemozoin molecule.118 However, the spontaneous Raman cross-section is typically weak, making it unsuitable for early diagnosis. This can be enhanced by matching the laser wavelength to electronic transitions, known as resonance Raman scattering (RRS), of hemozoin.119,120 Remarkably, the total symmetric A1g modes are very intense for hemozoin (compared to hematin) when applying near-infrared excitation wavelengths.118 This enhancement may be attributed to excitonic interactions between aggregated porphyrin complexes at long excitation wavelengths. Another contribution comes from a broad z-polarized charge transfer transition that is centered at 860 nm, which is not observed in hemin or hematin.119 Furthermore, the coupling of Raman spectroscopy with partial dark-field effect,121 acoustic levitation,122 and external magnetic field123 has led to improved diagnostic capabilities. These advancements, however, are still not sufficient for early diagnosis of ‘ring’ stage infections.
A pronounced enhancement in the Raman signal is often achieved by leveraging the surface plasmon field of metallic nanostructures in contact (substrate), a technique known as surface-enhanced Raman spectroscopy (SERS).124 Using gold-coated G. Weskei butterfly wings as a substrate, Garrett et al. achieved high sensitivity (25 parasites/µL) in ‘ring’ stage infected cells.125 However, random hemozoin deposition and its tendency to form aggregates at the base of the conical wing nano-structures pose challenges in locating hot spots for detecting low parasitemia. Furthermore, hemozoin aggregation itself enhances the Raman peak intensity, making it unsuitable for accurately quantifying parasitemia. Moreover, common SERS substrates, such as silver nanoparticles (AgNPs),126 provided low sensitivity of 500 parasites/µL, but hemozoin aggregation using a core–shell magnetic Fe3O4@AgNPs in an external magnetic field enhances the sensitivity to 5 nM of β-hematin, equivalent to 30 parasites/µL.123 Another approach involved the in situ synthesis of AgNPs inside Plasmodium parasites, reducing the substrate-hemozoin distance and yielding a sensitivity of 2.5 parasites/µL.126 However, the chemical precursors used in this approach tend to convert hemoglobin (in uninfected h-RBCs in the blood) into heme and further hematin, which has identical Raman peaks as hemozoin under visible light excitation127), potentially leading to false interpretations. To address this challenge, an extension of the excitation wavelength from visible light to near-infrared can enable the differentiation of the spectra of hemozoin and hematin. In an effort to develop a point-of-care test, the team applied an in situ AgNPs synthesis approach to a SERS fluidic chip, which, however, resulted in a reduced sensitivity of 125 parasites/µL in the ring stage.128 In a recent SERS study employing gold nanostructures (AuNS),129 a high sensitivity of 0.1 P. falciparum parasites/µL was achieved, allowing for accurate diagnosis of 25 clinical samples from P. falciparum- and P. vivax-infected patients and healthy volunteers. However, this process requires a significant amount of time (30 min).
Another basic optical tool for material identification is Fourier transform infrared spectroscopy (FTIR). Slater et al.34 were the first to employ FTIR spectroscopy on purified hemozoin, identifying the presence of an iron carboxylate bond that links the heme units, forming dimers [see Fig. 2]. The distinctive hemozoin bands provide an excellent marker for developing an infrared-based diagnostic tool for malaria. This idea has been extensively explored by Bayden Wood and co-workers [see Fig. 8]. The team, initially, performed an infrared experiment on RBCs fixed onto a CaF2 substrate using synchrotron FTIR microspectroscopy and an artificial neural network to develop a diagnostic model.130 Principal component analysis (PCA) revealed distinct hemozoin bands as the parasite metamorphosed, enabling discrimination of intra-erythrocytic life-cycle stages. By coupling a synchrotron light source with a focal plane array (FPA) infrared microscope system, they were able to discriminate single i-RBCs within a field of uninfected cells.131
In another development, the team spatially resolved sub-cellular parasite organelles on a conventional and affordable ‘glass’ slide using a high-resolution FTIR imaging spectrometer (Agilent Technologies, Inc.), combined with an automated approach based on Partial Least Squares-Discriminant Analysis (PLS-DA).132 In another study,133 the team applied a combination of Atomic Force Microscopy infrared (AFM-IR) and Raman spectroscopy to probe the localization of subcellular components within P. falciparum-infected RBCs using hyperspectral multimodal imaging. These merged images offer much more valuable information compared to individual modalities, providing a more comprehensive understanding of the cell composition and resulting in improved model predictions. However, these mid-IR techniques130,131,132,133 are not suited as routine diagnostic tools.
In a laboratory setting, Wood and co-workers134 demonstrated the potential of Attenuated Total Reflectance (ATR)-FTIR spectroscopy, in combination with multivariate data analysis tools, for a rapid (<3 min) malaria diagnosis (and quantification) with the required ease of sample preparation and high sensitivity. The absolute detection limit was found to be <1 parasite/µL for cultured early ‘ring’ stage parasites. It is noted that biochemical parameters, including lower levels of glucose, high levels of urea, and metabolic changes produced by the Plasmodium spp. could interfere in the prediction of clinical parameters and vice versa. To resolve this, the aforementioned methodology was successfully applied to diagnose malaria, glucose, and urea simultaneously from a single ATR-FTIR spectrum recorded from a drop of blood.135 In order to eliminate the problematic RBCs fixing and drying steps, Martin et al. applied ATR–FTIR to aqueous physiological blood samples (including strongly IR-absorbent plasma, and water) under the action of three common anticoagulants: sodium citrate, potassium EDTA and lithium heparin.136 PCA models built using aqueous physiological samples showed less influence from anticoagulants compared to the dried samples, presumably due to a dilution of anticoagulants by water. PLS-regression analysis (PLS-RA) indicated that only heparin individually gave the best prediction capability for low parasitemia (<0.1%).
Magneto-optical based technology
Malaria-infected blood containing hemozoin nanocrystals can truly be considered a magnetic fluid. An external magnetic field exerts a torque on hemozoin (elongated) crystals, aligning them unidirectionally such that the hard magnetic axis (at ∼60° to the crystallographic long-axis74) lies normal to the field. As a result, hemozoin exhibits a preferred direction of optical absorption (optical anisotropy) under the action of linearly polarized light (optical dichroism).137 This is analogous to the Cotton-Mouton effect, which is the birefringence of magnetic fluids in a transverse magnetic field. Thus, the magnetic anisotropy of hemozoin gives rise to optical dichroism, termed magnetically-induced linear dichroism (MLD), and hemozoin crystals behave like a dichroic polarizer.74,137
Newman and co-workers138 first developed a simple magneto-optical diagnostic (MOD) tool that measures the difference in optical transmission through a fluid (e.g., blood) medium in zero and a constant applied magnetic field (0.6 T) with randomly oriented and magnetically aligned hemozoin crystals, respectively. The portable device can detect a concentration of hemozoin in blood as low as 5 ng/µL, notably in a quick turnaround time of 1 min. This development was followed by a similar portable device called Gazelle,139 which exhibited a diagnostic capacity of ≥50 parasites/µL for P. falciparum within 1 min. Another portable optical diagnostic system (PODS)140 brings a magnet close to the sample, thus pulling β-hematin out of the optical path, resulting in higher transmitted intensity. The difference between the two signals (magnets close and away) can detect β-hematin concentrations as low as 8.1 ng/mL in whole rabbit blood; however, the diagnosis takes a somewhat longer time of 10 min.
Newman and co-workers also exploited the MLD of hemozoin using polarization modulation of the laser beam in two orthogonal (parallel and perpendicular) directions with respect to the (fixed) magnetic field direction.137 The proof of principle was demonstrated for a detection of less than 1 µg/mL concentration of β-hematin in whole fresh blood and more notably, hemozoin within live parasitized cells, promising an in vivo (non-invasive) diagnostic. Indeed, simulations on MLD of hemozoin in a medium resembling fingertip physiology indicated a detection capability of less than 0.02 µg/mL (equivalent to ≈33 parasites/µL) in a non-invasive methodology within a minute.141
In a similar MLD-based diagnosis, Butykai et al.74 measured the polarization modulation of the (transmitted) light beam by magnetically driven rotation of (dichroic) hemozoin crystals, thus termed as rotating-crystal MOD (RMOD) technology [see Fig. 9a]. The light wavelength & magnet rotation frequency are optimized for the best signal-to-noise ratio for the detection of β-hematin crystals in blood, down to a concentration of 0.015 µg/mL, which is mainly limited by a frequency-independent background signal, possibly originating from the Voigt effect of the medium. With this optimized setting, RMOD for in vitro cultured P. falciparum parasites achieved a detection capability down to ∼40 parasites/µL of (lysed) blood in the ring stage and even less than 10 parasites/µL in the later stages of intra-erythrocytic malaria cycle.142 The RMOD methodology is further validated in mice studies,143,144 revealing highly sensitive (not less than light microscopy) in vivo monitoring of hemozoin production during progression and clearance dynamics during and after the treatment. The RMOD technology also demonstrated a quantitative assessment of antimalarial drug potency145 at very short incubation times of 6–10 h compared to conventional methods [see Fig. 9b]. The authors intend to examine RMOD capability for the assessment of drug inhibitory effects in a stage-specific format.
The magnetism of hemozoin was recently employed in a magneto-chromatography online device,146,147 wherein i-RBCs were magnetophoretically concentrated (in a gradient magnetic field by SPM microbeads), and hemozoin crystals were isolated by rinsing in an alkaline solution and quantified by optical spectrophotometry. This methodology can detect hemozoin concentrations down to 0.033 µg/mL of whole blood, broadly equivalent to 55 parasites/µL in in vitro cultured samples, within 15 min.
Another methodology to measure tiny magnetic signals is magnetic resonance-based techniques using optically active spin defects, such as NV centers in diamond.82,83,84 NV-based diamond quantum sensors have shown a sensitivity down to a single nuclear (electron) spin at room temperature, compared to the minimum 1012 (109) nuclear (electron) spins typically needed for conventional MRI. NV-ODMR technology, with the striking blending of high sensitivity and nanoscale resolution, has previously shown excellent promise for biosensing,148 including single DNA,149,150 living cells,151 magnetically labeled cancer cells,152 single proteins153 and neurons,154 among others. Fescenko et al.87 have recently demonstrated its potential for detecting individual hemozoin nanocrystals, with the promise of a highly sensitive, label-free malaria diagnostic.
Field evaluation
After the successful demonstration of hemozoin sensing-based diagnostics in in vitro studies involving cultured P. falciparum parasites or β-hematin in blood suspensions in a laboratory setting, various of these methodologies have been evaluated for sensitivity (true positive rate) and specificity (true negative rate) in field/clinical setting. The magnetic-based NMR relaxometry technique was evaluated in an animal (mice) study58 in a blinded test on a large sample scale (n = 58). For the early stage of infection (for initial 6 days), micro-NMR demonstrated high sensitivity and specificity of 97.9% and 90%, respectively, outperforming blood-smear microscopy, which had a sensitivity of 774.9% and specificity of 82%. Furthermore, the non-invasive diagnostic functionality of different hemozoin sensing technologies has also been exploited in animal studies.106,115
TMek technology, developed by Bertacco and co-workers79,102 in 2020, was applied in a preclinical study in Cameroon, using light-microscopy as a reference measurement. TMek was evaluated with blood samples (n = 75) from peripheral (venous), while only a few (n = 10) samples were taken using a capillary (finger prick). The two methodologies gave no false negative results, proving a 100% sensitivity of TMek. The test with capillary samples also gave no false negatives, resulting in a specificity of 100%. On the contrary, large-scale testing with peripheral samples gave 9 false positives, leading to a specificity of 69%. This discrepancy may arise from the fact that fingerprick samples were tested within 5 hours, while peripheral samples were examined up to 16 h after sampling. Furthermore, hemoglobin (in healthy samples) can degrade to met-Hb, resulting in paramagnetic corpuscles (with magnetic susceptibility close to i-RBCs), leading to false positives. Nevertheless, TMek with prick-test, despite testing on a small sample scale, promises a highly sensitive and specific malaria diagnosis in a clinical setting.
The ATR-FTIR technology, developed by Wood and his team,134 was first evaluated in a field trial in a malaria-endemic country, namely Thailand.155 The blood samples from 318 patients were acquired in four regional clinics and tested using two portable ATR–FTIR spectrometers operated via a user-friendly software interface to the “Cloud”. An independent test set based on PCR assay results was used as the “gold standard” to cross-validate the spectroscopic analysis. Data were analyzed using a machine learning classification (support vector machines; SVM), which yielded a 92% sensitivity and 97% specificity. This outperformed PLS-DA modeling, which achieved 90% sensitivity and 91% specificity. Similarly, Mwanga et al.156 demonstrated the potential of ATR–FTIR spectroscopy coupled with supervised machine learning to diagnose malaria in human dried blood spots (DBS) obtained from field surveys of naturally infected individuals in a malaria-endemic community in Tanzania. The study considered 296 samples in total and supervised logistic regression models attained sensitivity and specificity of 91.7% and 92.8%, respectively for predicting P. falciparum infections, whereas 85% and 85%, respectively for predicting mixed (P. falciparum and P. ovale) infections.
The magneto-optical diagnostics (MOD) tool, developed by Newman and co-workers,138 was tested on 217 clinical samples comprising patients with malaria and other diseases (e.g., sickle cell anemia) from endemic countries and healthy non-endemic controls. In a pre-examination, light microscopy confirmed that samples could be quantified to a parasitemia level ≥600 parasites/µL. The MOD technique diagnosed the (lysed) blood samples with a sensitivity and specificity of 78.8% and 74.6%, respectively, when using the PCR assay as the reference standard. The false positive rate was contributed by sickle cell patients and, more worryingly, from healthy controls, which was attributed to contaminations from the assembly process and/or blood lysing. Notably, MOD was performed on long-stored blood samples, which may have resulted in hemozoin agglutination (with no magneto-optical response), contributing to false negatives. The false signals may also be originated by differences in hematocrit levels for individuals. The team also examined another magneto-optical technology, accounting for MLD of hemozoin, on a small scale of 13 patients (including sickle cell anemia) and successfully diagnosed in agreement with RDTs.137 The MLD-based non-invasive magneto-optic (NIMO) device is also evaluated in a fingertip probe on a small sample of 46 patients using light microscopy as the reference technique.141 This gave a low sensitivity of 26.7% and a moderate specificity of 80.6%. Yet, as a non-invasive diagnostic, it is highly encouraging. The authors addressed this low sensitivity as a consequence of the man-machine interface (constant finger position and pressure).
Another portable MOD device, Gazelle (LoD = 50 parasites/µL),139 were tested on (lysed) blood samples from 262 febrile patients with microscopy-confirmed (P. falciparum and P. vivax infected) samples having parasitemia ≥ 41 parasites/µL. The device diagnosed the samples within 1 min with an overall sensitivity and specificity of 97.6% and 96.8% (with 100% accuracy for P. vivax infections only) using light microscopy as the reference standard. However, the overall sensitivity decreased noticeably to 82.1%, using the PCR assay as the reference standard. The sensitivity improved to 85.4% upon exclusion of patients with a recent malaria history. Following this development, Gazelle conducted a study on 276 and 180 specimens (with P. vivax infections only) from the Brazilian157 and Peruvian Amazon,158 respectively, revealing a sensitivity of 72.1% and 88.2% using PCR as the gold standard. More specifically, the sensitivity for specimens with parasitemia>200 parasites/µL achieved 98.67%, however, it decreased to 12.5% for lower parasitemia.158
MLD-based RMOD technology74 was also examined on clinical samples from 956 suspected malaria patients in a high-transmission region.159 Samples from malaria-naive volunteers were considered as a background for the MLD signal, however, most malaria-negative samples (from light microscopy as gold standard) showed a higher signal than the background. Therefore, a considerably higher cut-off level (for decision-making) was set to achieve the best overall sensitivity and specificity of 82% and 84%, respectively. This improved to 87% and 88%, respectively for only P. vivax infections (due to a 10-fold higher average magneto-optical signal). The overall sensitivity also improved to 86% upon exclusion of samples from recently infected patients in high-transmission settings. The authors hypothesized the persistence of a significant amount of hemozoin in peripheral blood in a considerable population in high-transmission settings. More importantly, the determination of a cut-off MLD level relies on using a conventional diagnostic method. Nevertheless, in low-transmission settings, the cut-off level, particularly for P. vivax infections, should approach the background signal (from naive samples), leading to a significantly improved malaria diagnosis.
Outlook
Critical for the control and elimination of malaria is a rapid and accurate (quantitative) diagnosis of the disease, including the capacity to have ultra-sensitive and highly specific detection (Plasmodium species identification) in early (ring and early trophozoite) stages, and to identify the appropriate anti-malarial drug for the treatment. None of the current clinical methods (e.g., light microscopy, molecular approaches, and serological tests) offer these functionalities in a single test [see Table 3 and Fig. 10]. With this respect, the emergence of hemozoin-based point-of-care technologies augurs well to achieve the required sensitivity in a rapid time to stratify asymptomatic individuals in malaria high-transmission regions. The rich magnetic and optical properties of hemozoin due to the presence of unfilled electrons in the sub-orbitals of Fe3+ ions make hemozoin an excellent target not only for clinical diagnosis but also provide unique information for designing and clinical testing novel anti-malarial drugs at very short incubation times in comparison to conventional techniques [see Table 4].
In the search of appropriate anti-malarial drug resistance, the essential question is how malaria parasites cope with toxic (free) heme, or, more specifically, how hydrogen bonding in the hemozoin crystal occurs and whether this is a nonenzymatic or enzymatic process.
The recent application of high-resolution microscopy methods such as electron microscopy, soft X-ray tomography, etc.46,51,160 has offered a better understanding of crystal morphology, growth medium, and important factors leading to crystal growth and inhibition. However, the origin of hemozoin nucleation is still unresolved. The reason is understanding hydrogen-bonding networks in such nanocrystals with traditional X-ray crystallography methods is difficult. Using advanced 3D electron diffraction,161 Matz et al. demonstrated that the technique was capable of determining the hemozoin crystalline order under the deregulation of PbPV5 proteins in vivo.51 Meanwhile, electron diffraction also often suffers from accuracy issues related to H-atom positions and identifying atoms with similar atomic numbers (carbon, nitrogen, and oxygen). In such a case, the combination of electron and NMR crystallography has been shown to be effective in elucidating complex hydrogen-bonding structures.162 Future research seeks such advanced investigation of the heme detoxification process in vivo to better understand the mechanisms underlying hemozoin nucleation for the development of effective antimalarial drugs.
The peculiar magnetism in hemozoin has received progressively increasing attention, both for understanding at the fundamental level and its use as a tool for malaria diagnostics. The magnetometry studies, mostly via lab-grown β-hematin74,76,77,78 suggest a puzzling PM/SPM ground state, although primary NV-ODMR experiments87 put forward a SPM-like behavior for very small crystals, whereas a PM behavior for bigger crystals. This contradicts the expected SPM-FM transition, as the crystal size increases, in conventional nanomagnets.80,81 Moreover, natural hemozoin typically has a long axis of 200–600 nm, primarily depending upon the Plasmodium species.37 Thus, future magnetic studies on hemozoin/β-hematin with controlled variation in crystal size and shape will help to better understand its magnetic ground state and exploit it for stage- and species-specific diagnostic. Despite a lack of clarity in the magnetic picture of hemozoin, it is employed in various magnetic-based malaria diagnostic techniques. Meanwhile, it is observed that ingestion of hemoglobin by Plasmodium parasites initiates two simultaneous processes: free heme is converted to hemozoin crystals,30 as well as hemoglobin is oxidized into metHb,27 both containing Fe3+ (high-spin S = 5/2, paramagnetic) ions. Furthermore, ingestion of metHb releases non-heme iron undergoing accumulation into ferritin or hemosiderin,163 which are also SPM in nature.164 Thus, malaria-infected i-RBCs also have a magnetic background signal from (specific to individual) non-hemozoin magnetic entities55 i.e., iron-rich hemoglobin in different forms, which recommends advanced data analysis methods like machine learning to speed up the field-implementation of magnetic technologies.
Very recently, Kung et al. exploited machine learning to understand the complex, yet specific and unique molecular fingerprinting of a single drop of blood.61,165 The group developed a new methodology to capture the 2D T1–T2 (NMR) correlational spectroscopy by harvesting the highly efficient multidimensional inverse Laplace decomposition technique. Machine learning techniques were introduced to reduce the dimensionality by transforming the complex 3D contour plots (from 2D NMR measurements) into 2D scatter plots and user-friendly information for point-of-care disease diagnosis and monitoring [see Fig. 11]. The clinical application of this technology enables the direct analysis of human whole blood in various physiological (e.g., oxygenated/deoxygenated states) and pathological (e.g., blood oxidation, hemoglobinopathies) conditions.24,93 A highly time- and patient-specific ‘molecular fingerprint’ can be obtained in minutes. In a blind test on 32 anonymized subjects, the supervised learning models demonstrated a higher sensitivity of 88.5% and specificity of 88.7% within 30 s, outperforming trained technicians with 81.1% sensitivity and 72% specificity in 10 min. Thus, the higher order of (pseudo-)dimensionality (e.g., 2D- or multi-dimensional) in time-domain NMR coupled with machine learning may substantially improve the speed and accuracy of object identification.61,100 This technique can be directly applicable to malaria infection17,99 and such progress is currently under way.
Exploiting nanofabrication has revolutionized medical diagnostic methods as new detection modalities and transducers were invented. Magnetic nanotechnologies, such as TMR,101 have shown considerable potential in detecting malaria. The ability to integrate spintronic sensors based on the TMR effect into standard complementary metal-oxide semiconductor (CMOS) wafers is a fundamental step toward large-scale production, dissemination, and commercialization of the research. Furthermore, the integration of spintronics and CMOS technology can create hybrid devices with functionalities that are not available in either of the two individual technologies. Further improvement of the TMR-based diagnostic device will open new possibilities for the early-stage detection of malaria. The microchip-based TMek79 is a quantitative and stage-selective diagnostic tool for an effective screening of the population but improvements in apparatus engineering, scaling up chip production, and advanced decision-making are needed to mature the technology for field deployment.
The optical properties of hemozoin have been harnessed in numerous technologies, as discussed in “Optical-based technology”, to enable a rapid and sensitive malaria diagnosis at a low cost. In pursuit of this goal, reflectance spectrophotometry107 has demonstrated its potential for early and sensitive malaria diagnostics using thin film (band-pass) filters. These characteristics can be further improved through optimized fabrication, better materials, and the inclusion of additional commercial filters. It is suggested that an accurate algorithm may further enhance decision-making for a more specific diagnostic. The authors aim to integrate these filters into a single chip for non-invasive malaria diagnosis among asymptomatic individuals in high-transmission settings.
Another optical-based fingerprint of malaria is Raman spectroscopy of hemozoin. However, in its spontaneous form, sensitivity is too low for early diagnosis, even with resonant excitation and magnetic field enrichment123 and optical tweezers.166 Subsequent studies have explored various metallic nanostructures to enhance the Raman cross-section of hemozoin, resulting in ultrasensitive malaria diagnosis.126,129 Nonetheless, the instantaneous growth of nanostructures requires a laboratory setting and is time-consuming, while their short shelf-life on a commercial scale poses a challenge. Other approaches have attempted to use naturally occurring nano-structures125 and on-chip nanostructures growth,128 but a propensity for hemozoin aggregation and the conversion of healthy hemoglobin to hematin in these approaches may limit their clinical performance. In a close development, antigen-based SERS testing on 190 clinical samples from endemic regions167 differentiated between Ebola and malaria with high specificity of 97.9% and 99.6%, respectively. However, this method is also time-consuming (30 min). Overall, the rapid, consistent, and uniform synthesis of SERS agents, especially on micro-optofluidic chips,168 remains an open question for achieving rapid and accurate malaria diagnosis.
In optical technologies, spectroscopy-based ATR–FTIR sensing of hemozoin, with the aid of machine learning, has demonstrated its highest potential for point-of-care malaria diagnosis in two clinical studies conducted in low-resource settings within malaria-endemic countries.155,156 ATR–FTIR is both cheap and easy to use, requiring minimal expertise and little to no sample preparation. However, improvements are required to expedite the measurements, including the drying procedure and subsequent cleaning of the ATR crystal. To address this concern, an affordable, disposable coverslip169 has been proposed to facilitate the collective drying of multiple samples for successive measurements. PLS-RA has exhibited the ability to detect and quantify parasitemia in the 0–5% range. More recently, NIR spectroscopy has been applied to malaria diagnosis. Notable research in this regard is the successful detection and quantification of P. falciparum-infected malaria in dried blood samples using a “Matchbox” size spectrometer170 and aqueous blood samples using a combination of NIR and UV-visible spectroscopy.171 In a recent study, visible microspectrophotometry was applied to discriminate the different stages of asexual blood stages of P. falciparum parasites at single cell level in functional erythrocytes.172
The success of machine learning with 2D NMR relaxometry and ATR–FTIR techniques inspires us to exploit it for extracting maximum information from hemozoin-based malaria diagnostics. Deep learning and machine learning methods have recently accomplished a significant breakthrough in automating the conventional microscopic examination of malaria in the perspective of sensitivity and reduced labor-force. An exceptional accuracy of up to 99.9% has been achieved.173,174,175,176,177 However, reliability still poses a significant challenge as humans are widely regarded to have superior judgment as compared to computer algorithms. Nonetheless, deep learning models have reportedly made significant advancements in recent times, indicating the potential for machines to eventually take over human tasks. Indeed, there is a surge in the utilization of machine learning for novel medical diagnostics.178,179 Of relevance to us, its combination with Raman spectroscopy has offered a high sensitivity to any tiny changes in spectral features for different biological entities,180 resulting in significant improvements in diagnostic capabilities for a number of diseases e.g., hepatitis B,181 typhoid and dengue infections,182 etc. Of great interest, this combination can classify the malaria-infected and dengue-infected donors with an efficiency of 83.3%, while individually achieving a diagnostic sensitivity/specificity of 95.29% and 95.84%, respectively, against healthy control groups, respectively.183 More recently, Raman spectroscopy using PCA-DA successfully diagnosed COVID-19 infection with 87% sensitivity and 100% specificity.184 In a preliminary study,185 ATR–FTIR spectroscopy was also exploited for the rapid diagnosis of COVID-19, with machine learning analysis predicting it with a moderate accuracy of 78.4%. Wood and co-workers186 explored transflection infrared spectroscopy to diagnose COVID-19 in saliva samples. Transfection offers several advantages over ATR–FTIR, including batch sample drying, infrequent instrument cleaning (to avoid health risks for healthcare workers), and approximately three times larger light absorbance. Overall, spectroscopy-based Raman, ATR–FTIR, and NIR (or a combination of them) with machine learning analysis can help to stratify malaria from other similar symptomatic diseases, such as dengue and COVID-19, from a single sample, particularly in the current pandemic scenario.7
Magneto-optical technologies, primarily developed in a portable format, offer a rapid diagnostic approach for field conditions, proving especially effective in low-resource settings. In both the methodology, simplest MOD (e.g., Gazelle) and MLD (e.g., RMOD) devices demonstrated a satisfactory performance, particularly for P. vivax infections (a major portion of infections outside endemic areas), with sensitivities on par with or superior to light microscopy. However, these studies have identified several key factors responsible for degradation in their performance. The primary challenges are the need for fresh samples (to avoid hemozoin agglutination) and blood lysing. Similar kinds of other diseases (e.g., sickle cell anemia) affecting magnetic fingerprints of blood and the potential persistence of residual hemozoin from previous infections in endemic regions can contribute to false signals. Additionally, variable hematocrit levels among individuals and associated background signals introduce further complexity to the decision-making process. These challenges highlight the necessity for several levels of advancements, such as the integration of microfluidics and algorithmic decision-making with machine learning, to enhance diagnostic performance.
Another magneto-optic-based NV-ODMR technology has demonstrated the capability to image the individual hemozoin nanocrystals.87 In the bio-physical processes, the capability of detecting the molecular machinery remains a significant technological challenge, primarily due to poor sensitivity and/or selectivity and specific sample requirements for most bioimaging methods. In recent years, NV sensors have been successfully employed for imaging various biomedical samples, including single living cells, under ambient conditions.148 These NV-based ultrasensitive experiments, however, incorporate several bulky and expensive components in a laboratory-based setting, typically utilizing table-top confocal optical systems for single NV measurements. Consequently, the large size and complexity of these setups make them unsuitable for diagnostic applications in field conditions. Nevertheless, work is rapidly progressing on the miniaturization of NV-based diamond quantum sensors, featuring simpler optical setups, into a simplified and transportable form.187,188,189,190 This can offer one of the best tools for bioimaging and biodiagnostics available today. NV-based measurements can also play a part in understanding the developmental stages of malaria, particularly by monitoring the formation of single hemozoin nanocrystals in living Plasmodium-infected cells, shedding new light on the hemozoin nucleation mechanism and the discovery of novel antimalarial drugs.
Concluding remarks
Currently, many hemozoin-based diagnostic technologies are able to compete with, or even outperform, conventional microscopy and RDT methods, offering notably higher sensitivity (approaching PCR-based methods) and delivering rapid results within a few minutes.
The primary challenges before hemozoin-based diagnostic to reach an ideal format are species-specific diagnosis and the ability to distinguish fresh hemozoin, generated within i-RBCs, from the residual content within white blood cells (WBCs) resulting from phagocytosis of hemozoin in previous malaria infections. Several hemozoin-based research groups99,139,159 are currently aspiring for future improvements in species differentiation by leveraging hemozoin crystal morphology (size and shape),37 and exploring multi-dimensionality in time-domain NMR with the aid of machine learning,59,61 etc. On another front, an in vivo optical absorbance study, involving mice, has demonstrated the potential to discriminate hemozoin in i-RBCs and WBCs based on intensity features and hemozoin crystal size, and the results were validated with similar findings for P. falciparum blood smears with conventional light microscopy.191 Nevertheless, it is worth noting that hemozoin gets cleared from the bloodstream within a few days,37 in contrast to the longer persistence of antigens (e.g., HRPII and LDH), which can remain detectable for several weeks to more than a month.192 These factors recommend hemozoin sensing over RDT for a more accurate diagnosis.
In summary, ultrasensitive hemozoin-based techniques are being developed with tremendous potential for early and highly specific malaria diagnosis. These methods can also contribute to the development of targeted drugs and vaccines to combat the disease. Nevertheless, several technical challenges must be addressed to achieve their highest potential, especially as scalable and cost-effective technologies suitable for field deployment in remote, under-resourced regions where malaria is endemic. As research is rapidly progressing toward the development of inexpensive, miniaturized, or lab-on-chip devices that can be battery-powered, the tantalizing prospect of personalized medicine is on the horizon. Integrating mobile phones with diagnostic tools enables data to be sent to the Cloud and analyzed in real-time.155 The mobile interface also provides a global positioning system that can be used for epidemiological surveillance.
Machine learning, which makes machines smarter, has become more popular of late, and it is likely another game-changer that can expedite the field implementation of emerging spectroscopic-based technologies for malaria eradication and elimination strategies in the future. Human being is slowly (but surely) in winning the race over the war of malaria. Strong political will (e.g., human capital, funding agency), however, is needed to accelerate the translation of these technologies into field settings, as most of these endemic regions are in developing regions.
References
Organization, W. H. et al. World malaria report 2020: 20 years of global progress and challenges (2020).
Organization, W. H. Global technical strategy for malaria 2016–2030 (2015).
Menard, D. & Dondorp, A. Antimalarial drug resistance: a threat to malaria elimination. Cold Spring Harb. Perspect. Med. 7, 025619 (2017).
Organization, W. H. et al. World Malaria Report 2021 (2021).
Rts, S.: Clinical trials partnership. Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386, 31–45 (2015).
Calderaro, A. et al. Malaria diagnosis in non-endemic settings: the European experience in the last 22 years. Microorganisms 9, 2265 (2021).
Nghochuzie, N. N., Olwal, C. O., Udoakang, A. J., Amenga-Etego, L. N.-K. & Amambua-Ngwa, A. Pausing the fight against malaria to combat the covid-19 pandemic in Africa: is the future of malaria bleak? Front. Microbiol. 11, 1476 (2020).
Aborode, A. T. et al. Fighting covid-19 at the expense of malaria in africa: the consequences and policy options. Am. J. Trop. Med. Hyg. 104, 26 (2021).
Organization, W. H. et al. A Framework for Malaria Elimination (2017).
Mbanefo, A. & Kumar, N. Evaluation of malaria diagnostic methods as a key for successful control and elimination programs. Trop. Med. Infect. Dis. 5, 102 (2020).
Pham, N. M., Karlen, W., Beck, H.-P. & Delamarche, E. Malaria and the ‘last’parasite: how can technology help? Malar. J. 17, 1–16 (2018).
Amir, A., Cheong, F.-W., De Silva, J. R. & Lau, Y.-L. Diagnostic tools in childhood malaria. Parasites Vectors 11, 1–12 (2018).
Krampa, F. D., Aniweh, Y., Kanyong, P. & Awandare, G. A. Recent advances in the development of biosensors for malaria diagnosis. Sensors 20, 799 (2020).
Coronado, L. M., Nadovich, C. T. & Spadafora, C. Malarial hemozoin: from target to tool. Biochim. Biophys. Acta 1840, 2032–2041 (2014).
Baptista, V., Peng, W. K., Minas, G., Veiga, M. I. & Catarino, S. O. Review of microdevices for hemozoin-based malaria detection. Biosensors 12, 110 (2022).
Baptista, V. et al. The future in sensing technologies for malaria surveillance: a review of hemozoin-based diagnosis. ACS Sens. 6, 3898–3911 (2021).
Dupr´e, A., Lei, K.-M., Mak, P.-I., Martins, R. P. & Peng, W. K. Micro-and nanofabrication nmr technologies for point-of-care medical applications—a review. Microelectron. Eng. 209, 66–74 (2019).
Peng, W. K., Paesani, D. Omics meeting Onics: towards the next generation of spectroscopic-based technologies in personalized medicine. (Multidisciplinary Digital Publishing Institute, 2019).
Cruz, A. & Peng, W. K. Perspective: cellular and molecular profiling technologies in personalized oncology. J. Personalized Med. 9, 44 (2019).
Kasetsirikul, S., Buranapong, J., Srituravanich, W., Kaewthamasorn, M. & Pimpin, A. The development of malaria diagnostic techniques: a review of the approaches with focus on dielectrophoretic and magnetophoretic methods. Malar. J. 15, 1–14 (2016).
Chen, K., Perlaki, C., Xiong, A., Preiser, P. & Liu, Q. Review of surface enhanced Raman spectroscopy for malaria diagnosis and a new approach for the detection of single parasites in the ring stage. IEEE J. Sel. Top. Quantum Electron. 22, 179–187 (2016).
Perez-Guaita, D. et al. Parasites under the spotlight: applications of vibrational spectroscopy to malaria research. Chem. Rev. 118, 5330–5358 (2018).
Goh, B. et al. The application of spectroscopy techniques for diagnosis of malaria parasites and arboviruses and surveillance of mosquito vectors: a systematic review and critical appraisal of evidence. PLoS Neglect. Trop. Dis. 15, 0009218 (2021).
Loh, T. P., Peng, W. K., Chen, L. & Sethi, S. K. Application of smoothed continuous labile haemoglobin a1c reference intervals for identification of potentially spurious hba1c results. J. Clin. Pathol. 67, 712–716 (2014).
Maier, A. G., Matuschewski, K., Zhang, M. & Rug, M. Plasmodium falciparum. Trends Parasitol. 35, 481–482 (2019).
Miller, L. H., Ackerman, H. C., Su, X.-Z. & Wellems, T. E. Malaria biology and disease pathogenesis: insights for new treatments. Nat. Med. 19, 156–167 (2013).
Francis, S. E., Sullivan, D. J. & Goldberg, D. E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51, 97–123 (1997).
Sigala, P. A. & Goldberg, D. E. The peculiarities and paradoxes of plasmodium heme metabolism. Annu. Rev. Microbiol. 68, 259–278 (2014).
Kumar, S. & Bandyopadhyay, U. Free heme toxicity and its detoxification systems in human. Toxicol. Lett. 157, 175–188 (2005).
Egan, T. J. Haemozoin formation. Mol. Biochem. Parasitol. 157, 127–136 (2008).
Weissbuch, I. & Leiserowitz, L. Interplay between malaria, crystalline hemozoin formation, and antimalarial drug action and design. Chem. Rev. 108, 4899–4914 (2008).
Herraiz, T., Guill´en, H., Gonz´alez-Pe˜na, D. & Ar´an, V. J. Antimalarial quinoline drugs inhibit β-hematin and increase free hemin catalyzing peroxidative reactions and inhibition of cysteine proteases. Sci. Rep. 9, 1–16 (2019).
de Villiers, K. A. & Egan, T. J. Heme detoxification in the malaria parasite: a target for antimalarial drug development. Acc. Chem. Res. 54, 2649–2659 (2021).
Slater, A. et al. An iron-carboxylate bond links the heme units of malaria pigment. Proc. Natl Acad. Sci. USA 88, 325–329 (1991).
Slater, A. & Cerami, A. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355, 167–169 (1992).
Pagola, S., Stephens, P. W., Bohle, D. S., Kosar, A. D. & Madsen, S. K. The structure of malaria pigment β-haematin. Nature 404, 307–310 (2000).
Noland, G. S., Briones, N. & Sullivan, D. J. Jr The shape and size of hemozoin crystals distinguishes diverse plasmodium species. Mol. Biochem. Parasitol. 130, 91–99 (2003).
Egan, T. J., Mavuso, W. W. & Ncokazi, K. K. The mechanism of β-hematin formation in acetate solution. parallels between hemozoin formation and biomineralization processes. Biochemistry 40, 204–213 (2001).
Dorn, A., Stoffel, R., Matile, H., Bubendorf, A. & Ridley, R. G. Malarial haemozoin/β-haematin supports haem polymerization in the absence of protein. Nature 374, 269–271 (1995).
Pisciotta, J. M. et al. The role of neutral lipid nanospheres in plasmodium falciparum haem crystallization. Biochem. J. 402, 197–204 (2007).
Jackson, K. E. et al. Food vacuole-associated lipid bodies and heterogeneous lipid environments in the malaria parasite, Plasmodium falciparum. Mol. Microbiol. 54, 109–122 (2004).
Egan, T. J. et al. Haemozoin (β-haematin) biomineralization occurs by self-assembly near the lipid/water interface. FEBS Lett. 580, 5105–5110 (2006).
de Villiers, K. A. et al. Oriented nucleation of β-hematin crystals induced at various interfaces: relevance to hemozoin formation. Cryst. Growth Des. 9, 626–632 (2009).
Hempelmann, E., Motta, C., Hughes, R., Ward, S. A. & Bray, P. G. Plasmodium falciparum: sacrificing membrane to grow crystals? Trends Parasitol. 19, 23–26 (2003).
Kapishnikov, S. et al. Aligned hemozoin crystals in curved clusters in malarial red blood cells revealed by nanoprobe X-ray Fe fluorescence and diffraction. Proc. Natl Acad. Sci. USA 109, 11184–11187 (2012).
Kapishnikov, S. et al. Oriented nucleation of hemozoin at the digestive vacuole membrane in Plasmodium falciparum. Proc. Natl Acad. Sci. USA 109, 11188–11193 (2012).
Mullick, D. et al. Diffraction contrast in cryo-scanning transmission electron tomography reveals the boundary of hemozoin crystals in situ. Faraday Discuss. 240, 127–141 (2022).
Jani, D. et al. Hdp—a novel heme detoxification protein from the malaria parasite. PLoS Pathog. 4, 1000053 (2008).
Chugh, M. et al. Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum. Proc. Natl Acad. Sci. USA 110, 5392–5397 (2013).
Matz, J. M. & Matuschewski, K. An in silico down-scaling approach uncovers novel constituents of the plasmodium-containing vacuole. Sci. Rep. 8, 1–12 (2018).
Matz, J. M. et al. A lipocalin mediates unidirectional heme biomineralization in malaria parasites. Proc. Natl Acad. Sci. 117, 16546–16556 (2020).
Pauling, L. & Coryell, C. D. The magnetic properties and structure of hemoglobin, oxyhemoglobin and carbonmonoxyhemoglobin. Proc. Natl Acad. Sci. USA 22, 210–216 (1936).
Coryell, C. D., Stitt, F. & Pauling, L. The magnetic properties and structure of ferrihemoglobin (methemoglobin) and some of its compounds. J. Am. Chem. Soc. 59, 633–642 (1937).
Weiss, J. J. Nature of the iron–oxygen bond in oxyhaemoglobin. Nature 202, 83–84 (1964).
Hackett, S., Hamzah, J., Davis, T. M. & St Pierre, T. Magnetic susceptibility of iron in malaria-infected red blood cells. Biochim. Biophys. Acta 1792, 93–99 (2009).
Furlani, E. Magnetophoretic separation of blood cells at the microscale. J. Phys. D 40, 1313 (2007).
Moore, L. R. et al. Hemoglobin degradation in malaria-infected erythrocytes determined from live cell magnetophoresis. FASEB J. 20, 747–749 (2006).
Peng, W. K. et al. Micromagnetic resonance relaxometry for rapid label-free malaria diagnosis. Nat. Med. 20, 1069–1073 (2014).
Peng, W. K., Chen, L., Boehm, B. O., Han, J. & Loh, T. P. Molecular phenotyping of oxidative stress in diabetes mellitus with point-of-care nmr system. NPJ Aging Mech. Dis. 6, 1–12 (2020).
Aime, S., Fasano, M., Paoletti, S., Arnelli, A. & Ascenzi, P. Nmr relaxometric investigation on human methemoglobin and fluoromethemoglobin. an improved quantitative in vitro assay of human methemoglobin. Magn. Reson. Med. 33, 827–831 (1995).
Peng, W. K., Ng, T.-T. & Loh, T. P. Machine learning assistive rapid, label-free molecular phenotyping of blood with two-dimensional nmr correlational spectroscopy. Commun. Biol. 3, 1–10 (2020).
Vu, C. et al. Reduced global cerebral oxygen metabolic rate in sickle cell disease and chronic anemias. Am. J. Hematol. 96, 901–913 (2021).
Heidelberger, M., Mayer, M. M. & Demarest, C. R. Studies in human malaria: I. The preparation of vaccines and suspensions containing plasmodia. J. Immunol. 52, 325–330 (1946).
Bohle, D. S., Debrunner, P., Jordan, P. A., Madsen, S. K. & Schulz, C. E. Aggregated heme detoxification byproducts in malarial trophozoites: β hematin and malaria pigment have a single s= 5/2 iron environment in the bulk phase as determined by epr and magnetic m¨ossbauer spectroscopy. J. Am. Chem. Soc. 120, 8255–8256 (1998).
Sienkiewicz, A. et al. Multi-frequency high-field epr study of iron centers in malarial pigments. J. Am. Chem. Soc. 128, 4534–4535 (2006).
Melville, D., Paul, F. & Roath, S. Direct magnetic separation of red cells from whole blood. Nature 255, 706–706 (1975).
Fairlamb, A. H., Paul, F. & Warhurst, D. C. A simple magnetic method for the purification of malarial pigment. Mol. Biochem. Parasitol. 12, 307–312 (1984).
Paul, F., Roath, S., Melville, D., Warhurst, D. & Osisanya, J. Separation of malaria-infected erythrocytes from whole blood: use of a selective high-gradient magnetic separation technique. Lancet 2, 70–71 (1981).
Kim, C. C., Wilson, E. B. & DeRisi, J. L. Improved methods for magnetic purification of malaria parasites and haemozoin. Malar. J. 9, 1–5 (2010).
Nam, J., Huang, H., Lim, H., Lim, C. & Shin, S. Magnetic separation of malaria-infected red blood cells in various developmental stages. Anal. Chem. 85, 7316–7323 (2013).
Zborowski, M. et al. Red blood cell magnetophoresis. Biophys. J. 84, 2638–2645 (2003).
Jaramillo, M. et al. Synthetic plasmodium-like hemozoin activates the immune response: a morphology-function study. PloS ONE 4, 6957 (2009).
Ncokazi, K. K. & Egan, T. J. A colorimetric high-throughput β-hematin inhibition screening assay for use in the search for antimalarial compounds. Anal. Biochem. 338, 306–319 (2005).
Butykai, A. et al. Malaria pigment crystals as magnetic micro-rotors: key for high-sensitivity diagnosis. Sci. Rep. 3, 1–10 (2013).
Wang, X., Peng, W. & Lew, W. Flux-closure chirality control and domain wall trapping in asymmetric magnetic ring. J. Appl. Phys. 106, 043905 (2009).
Gossuin, Y., Ndjolo, P. O., Vuong, Q. L. & Duez, P. Nmr relaxation properties of the synthetic malaria pigment β-hematin. Sci. Rep. 7, 1–7 (2017).
Giacometti, M. et al. Electrical and magnetic properties of hemozoin nanocrystals. Appl. Phys. Lett. 113, 203703 (2018).
Inyushin, M. et al. Superparamagnetic properties of hemozoin. Sci. Rep. 6, 1–9 (2016).
Giacometti, M. et al. A lab-on-chip tool for rapid, quantitative, and stage-selective diagnosis of malaria. Adv. Sci. https://doi.org/10.1002/advs.202004101 (2021).
Lu, A.-H., Salabas, E. E. & Sch¨uth, F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. 46, 1222–1244 (2007).
Kolhatkar, A. G., Jamison, A. C., Litvinov, D., Willson, R. C. & Lee, T. R. Tuning the magnetic properties of nanoparticles. Int. J. Mol. Sci. 14, 15977–16009 (2013).
Schirhagl, R., Chang, K., Loretz, M. & Degen, C. L. Nitrogen-vacancy centers in diamond: nanoscale sensors for physics and biology. Annu. Rev. Phys. Chem. 65, 83–105 (2014).
Doherty, M. W., Manson, N. B., Delaney, P. & Hollenberg, L. C. The negatively charged nitrogen-vacancy centre in diamond: the electronic solution. N. J. Phys. 13, 025019 (2011).
Bhallamudi, V. P. & Hammel, P. C. Nanoscale MRI. Nat. Nanotechnol. 10, 104–106 (2015).
Gould, M. et al. Room-temperature detection of a single 19 nm superparamagnetic nanoparticle with an imaging magnetometer. Appl. Phys. Lett. 105, 072406 (2014).
Tetienne, J.-P. et al. Scanning nanospin ensemble microscope for nanoscale magnetic and thermal imaging. Nano Lett. 16, 326–333 (2016).
Fescenko, I. et al. Diamond magnetic microscopy of malarial hemozoin nanocrystals. Phys. Rev. Appl. 11, 034029 (2019).
Zimmerman, P. A., Thomson, J. M., Fujioka, H., Collins, W. E. & Zborowski, M. Diagnosis of malaria by magnetic deposition microscopy. Am. J. Trop. Med. Hyg. 74, 568 (2006).
Kim, C., Hoffmann, G. & Searson, P. C. Integrated magnetic bead–quantum dot immunoassay for malaria detection. ACS Sens. 2, 766–772 (2017).
Peng, W. K., Samoson, A. & Kitagawa, M. Simultaneous adiabatic spinlocking cross polarization in solid-state NMR of paramagnetic complexes. Chem. Phys. Lett. 460, 531–535 (2008).
Peng, W. K. & Takeda, K. Efficient cross polarization with simultaneous adiabatic frequency sweep on the source and target channels. J. Magn. Reson. 188, 267–274 (2007).
Karl, S., Guti´errez, L., House, M. J., Davis, T. M. & Pierre, T. G. S. Nuclear magnetic resonance: a tool for malaria diagnosis? Am. J. Trop. Med. Hyg. 85, 815–817 (2011).
Peng, W. K., Chen, L. & Han, J. Development of miniaturized, portable magnetic resonance relaxometry system for point-of-care medical diagnosis. Rev. Sci. Instrum. 83, 095115 (2012).
Han, J. & Peng, W. K. Reply to” considerations regarding the micromagnetic resonance relaxometry technique for rapid label-free malaria diagnosis”. Nat. Med. 21, 1387–1389 (2015).
Gupta, M. et al. A sensitive on-chip probe–based portable nuclear magnetic resonance for detecting low parasitaemia plasmodium falciparum in human blood. Med. Devices Sens. 3, 10098 (2020).
Kong, T. F. et al. Enhancing malaria diagnosis through microfluidic cell enrichment and magnetic resonance relaxometry detection. Sci. Rep. 5, 1–12 (2015).
Thamarath, S. S., Xiong, A., Lin, P.-H., Preiser, P. R. & Han, J. Enhancing the sensitivity of micro magnetic resonance relaxometry detection of low parasitemia Plasmodium falciparum in human blood. Sci. Rep. 9, 1–9 (2019).
Di Gregorio, E. et al. Relaxometric studies of erythrocyte suspensions infected by Plasmodium falciparum: a tool for staging infection and testing anti-malarial drugs. Magn. Reson. Med. 84, 3366–3378 (2020).
Veiga, M. I. & Peng, W. K. Rapid phenotyping towards personalized malaria medicine. Malar. J. 19, 1–5 (2020).
Peng, W. K. Clustering nuclear magnetic resonance: machine learning assistive rapid two-dimensional relaxometry mapping. Eng. Rep. 3, 12383 (2021).
Li, Y. et al. Magnetoresistance sensor with analog frontend for lab-on-chip malaria parasite detection. In: 2021 IEEE International Symposium on Circuits and Systems (ISCAS) (IEEE, 2021), pp. 1–5.
Milesi, F. et al. On-chip selective capture and detection of magnetic fingerprints of malaria. Sensors 20, 4972 (2020).
Catarino, S. O. et al. Portable device for optical quantification of hemozoin in diluted blood samples. IEEE Trans. Biomed. Eng. 67, 365–371 (2019).
Lawrence, C. & Olson, J. A. Birefringent hemozoin identifies malaria. Am. J. Clin. Pathol. 86, 360–363 (1986).
B´elisle, J. M. et al. Sensitive detection of malaria infection by third harmonic generation imaging. Biophys. J. 94, 26–28 (2008).
Burnett, J. L., Carns, J. L. & Richards-Kortum, R. In vivo microscopy of hemozoin: towards a needle free diagnostic for malaria. Biomed. Opt. Express 6, 3462–3474 (2015).
Costa, M. S. et al. Multilayer thin-film optical filters for reflectance-based malaria diagnostics. Micromachines 12, 890 (2021).
Campuzano-Zuluaga, G., H¨anscheid, T. & Grobusch, M. P. Automated haematology analysis to diagnose malaria. Malar. J. 9, 1–15 (2010).
Shapiro, H. M., Ulrich, H. Cytometry in malaria: from research tool to practical diagnostic approach? (Wiley Online Library, 2010).
Cai, C. et al. In vivo photoacoustic flow cytometry for early malaria diagnosis. Cytom. Part A 89, 531–542 (2016).
Wang, S., Yang, C., Preiser, P. & Zheng, Y. A photoacoustic-surfaceacoustic-wave sensor for ring-stage malaria parasite detection. IEEE Trans. Circuits Syst. II 67, 881–885 (2020).
Wang, W. et al. Laser-induced surface acoustic wave sensing-based malaria parasite detection and analysis. IEEE Trans. Instrum. Meas. 71, 1–9 (2021).
Kishor, R. et al. Microfluidic device based on opto-acoustics for particle concentration detection (2017).
Pourabed, A. et al. A star shaped acoustofluidic mixer enhances rapid malaria diagnostics via cell lysis and whole blood homogenisation in 2 seconds. Lab a Chip 22, 1829–1840 (2022).
Lukianova-Hleb, E. Y. et al. Hemozoin-generated vapor nanobubbles for transdermal reagent-and needle-free detection of malaria. Proc. Natl Acad. Sci. USA 111, 900–905 (2014).
Kazarine, A. et al. Malaria detection by third-harmonic generation image scanning cytometry. Anal. Chem. 91, 2216–2223 (2019).
Tripathy, U. et al. Optimization of malaria detection based on third harmonic generation imaging of hemozoin. Anal. Bioanal. Chem. 405, 5431–5440 (2013).
Wood, B. R. et al. Raman imaging of hemozoin within the food vacuole of Plasmodium falciparum trophozoites. FEBS Lett. 554, 247–252 (2003).
Wood, B. R. et al. Resonance Raman spectroscopy reveals new insight into the electronic structure of β-hematin and malaria pigment. J. Am. Chem. Soc. 126, 9233–9239 (2004).
Frosch, T., Koncarevic, S., Becker, K. & Popp, J. Morphology-sensitive Raman modes of the malaria pigment hemozoin. Analyst 134, 1126–1132 (2009).
Wood, B. R. et al. Resonance raman microscopy in combination with partial dark-field microscopy lights up a new path in malaria diagnostics. Analyst 134, 1119–1125 (2009).
Puskar, L. et al. Raman acoustic levitation spectroscopy of red blood cells and Plasmodium falciparum trophozoites. Lab a Chip 7, 1125–1131 (2007).
Yuen, C. & Liu, Q. Magnetic field enriched surface enhanced resonance Raman spectroscopy for early malaria diagnosis. J. Biomed. Opt. 17, 017005 (2012).
P´erez-Jim´enez, A. I., Lyu, D., Lu, Z., Liu, G. & Ren, B. Surface-enhanced raman spectroscopy: benefits, trade-offs and future developments. Chem. Sci. 11, 4563–4577 (2020).
Garrett, N. L. et al. Bio-sensing with butterfly wings: naturally occurring nanostructures for users-based malaria parasite detection. Phys. Chem. Chem. Phys. 17, 21164–21168 (2015).
Chen, K., Yuen, C., Aniweh, Y., Preiser, P. & Liu, Q. Towards ultrasensitive malaria diagnosis using surface enhanced Raman spectroscopy. Sci. Rep. 6, 1–9 (2016).
Frosch, T. et al. In situ localization and structural analysis of the malaria pigment hemozoin. J. Phys. Chem. B 111, 11047–11056 (2007).
Yuen, C. et al. Towards malaria field diagnosis based on surface-enhanced Raman scattering with on-chip sample preparation and near-analyte nanoparticle synthesis. Sens. Actuators B https://doi.org/10.1016/j.snb.2021.130162 (2021)
Wang, W. et al. Antibody-free rapid diagnosis of malaria in whole blood with surface enhanced Raman spectroscopy using nanostructured gold substrate. Adv. Med. Sci. 65, 86–92 (2020).
Webster, G. T. et al. Discriminating the intraerythrocytic lifecycle stages of the malaria parasite using synchrotron ft-ir microspectroscopy and an artificial neural network. Anal. Chem. 81, 2516–2524 (2009).
Wood, B. R. et al. Diagnosing malaria infected cells at the single cell level using focal plane array Fourier transform infrared imaging spectroscopy. Analyst 139, 4769–4774 (2014).
Perez-Guaita, D. et al. High resolution ftir imaging provides automated discrimination and detection of single malaria parasite infected erythrocytes on glass. Faraday Discuss. 187, 341–352 (2016).
Perez-Guaita, D. et al. Multispectral atomic force microscopy-infrared nanoimaging of malaria infected red blood cells. Anal. Chem. 90, 3140–3148 (2018).
Khoshmanesh, A. et al. Detection and quantification of early-stage malaria parasites in laboratory infected erythrocytes by attenuated total reflectance infrared spectroscopy and multivariate analysis. Anal. Chem. 86, 4379–4386 (2014).
Roy, S. et al. Simultaneous ATR-FTIR based determination of malaria parasitemia, glucose and urea in whole blood dried onto a glass slide. Anal. Chem. 89, 5238–5245 (2017).
Martin, M. et al. The effect of common anticoagulants in detection and quantification of malaria parasitemia in human red blood cells by atr-ftir spectroscopy. Analyst 142, 1192–1199 (2017).
Newman, D. M. et al. A magneto-optic route toward the in vivo diagnosis of malaria: preliminary results and preclinical trial data. Biophys. J. 95, 994–1000 (2008).
Mens, P. F., Matelon, R. J., Nour, B. Y., Newman, D. M. & Schallig, H. D. Laboratory evaluation on the sensitivity and specificity of a novel and rapid detection method for malaria diagnosis based on magneto-optical technology (mot). Malar. J. 9, 1–8 (2010).
Kumar, R. et al. First successful field evaluation of new, one minute haemozoin-based malaria diagnostic device. EClinicalMedicine 22, 100347 (2020).
McBirney, S. E., Chen, D., Scholtz, A., Ameri, H. & Armani, A. M. Rapid diagnostic for point-of-care malaria screening. ACS Sens. 3, 1264–1270 (2018).
Newman, D. M., Matelon, R. J., Wears, M. L. & Savage, L. B. The in vivo diagnosis of malaria: feasibility study into a magneto-optic fingertip probe. IEEE J. Sel. Top. Quantum Electron. 16, 573–580 (2009).
Orb´an, A. et al. Evaluation of a novel magneto-optical method for the detection of malaria parasites. PloS ONE 9, 96981 (2014).
Orb´an, A. et al. Efficient monitoring of the blood-stage infection in a malaria rodent model by the rotating-crystal magneto-optical method. Sci. Rep. 6, 1–9 (2016).
Puk´ancsik, M. et al. Highly sensitive and rapid characterization of the development of synchronized blood stage malaria parasites via magnetooptical hemozoin quantification. Biomolecules 9, 579 (2019).
Moln´ar, P. et al. Rapid and quantitative antimalarial drug efficacy testing via the magneto-optical detection of hemozoin. Sci. Rep. 10, 1–11 (2020).
Roch, A., Prod´eo, J., Pierart, C., Muller, R. & Duez, P. The paramagnetic properties of malaria pigment, hemozoin, yield clues to a low-cost system for its trapping and determination. Talanta 197, 553–557 (2019).
Traore, O. et al. Development and validation of an original magnetochromatography device for the whole blood determination of hemozoin, the paramagnetic malaria pigment. Microchem. J. 157, 105043 (2020).
Zhang, T. et al. Toward quantitative bio-sensing with nitrogen–vacancy center in diamond. ACS Sens. 6, 2077–2107 (2021).
Teeling-Smith, R. M. et al. Electron paramagnetic resonance of a single NV nanodiamond attached to an individual biomolecule. Biophys. J. 110, 2044–2052 (2016).
Shi, F. et al. Singledna electron spin resonance spectroscopy in aqueous solutions. Nat. Methods 15, 697–699 (2018).
Le Sage, D. et al. Optical magnetic imaging of living cells. Nature 496, 486–489 (2013).
Glenn, D. R. et al. Single-cell magnetic imaging using a quantum diamond microscope. Nat. Methods 12, 736–738 (2015).
Shi, F. et al. Singleprotein spin resonance spectroscopy under ambient conditions. Science 347, 1135–1138 (2015).
Barry, J. F. et al. Optical magnetic detection of single-neuron action potentials using quantum defects in diamond. Proc. Natl Acad. Sci. USA 113, 14133–14138 (2016).
Heraud, P. et al. Infrared spectroscopy coupled to cloud-based data management as a tool to diagnose malaria: a pilot study in a malaria-endemic country. Malar. J. 18, 1–11 (2019).
Mwanga, E. P. et al. Detection of malaria parasites in dried human blood spots using mid-infrared spectroscopy and logistic regression analysis. Malar. J. 18, 1–13 (2019).
de Melo, G. C. et al. Performance of a sensitive haemozoin-based malaria diagnostic test validated for vivax malaria diagnosis in Brazilian Amazon. Malar. J. 20, 1–10 (2021).
Valdivia, H. O. et al. Field validation of a magneto-optical detection device (gazelle) for portable point-of-care plasmodium vivax diagnosis. PloS ONE 16, 0253232 (2021).
Arndt, L. et al. Magneto-optical diagnosis of symptomatic malaria in Papua New Guinea. Nat. Commun. 12, 1–10 (2021).
Wendt, C. et al. High-resolution electron microscopy analysis of malaria hemozoin crystals reveals new aspects of crystal growth and elemental composition. Cryst. Growth Des. 21, 5521–5533 (2021).
Gruene, T., Holstein, J. J., Clever, G. H. & Keppler, B. Establishing electron diffraction in chemical crystallography. Nat. Rev. Chem. 5, 660–668 (2021).
Guzm´an-Afonso, C. et al. Understanding hydrogen-bonding structures of molecular crystals via electron and nmr nanocrystallography. Nat. Commun. 10, 1–10 (2019).
Mohorovic, L. et al. Methemoglobinemia—a biomarker and a link to ferric iron accumulation in Alzheimer’s disease. Adv. Biosci. Biotechnol. 5, 12–18 (2014).
Tejada, J., Zhang, X., Del Barco, E., Hernandez, J. & Chudnovsky, E. Macroscopic resonant tunneling of magnetization in ferritin. Phys. Rev. Lett. 79, 1754 (1997).
Aggarwal, S., Peng, W. K. & Srivastava, S. Multi-omics advancements towards plasmodium vivax malaria diagnosis. Diagnostics 11, 2222 (2021).
Dasgupta, R., Verma, R. S., Ahlawat, S., Uppal, A. & Gupta, P. K. Studies on erythrocytes in malaria infected blood sample with Raman optical tweezers. J. Biomed. Opt. 16, 077009 (2011).
Sebba, D. et al. A point-of-care diagnostic for differentiating ebola from endemic febrile diseases. Sci. Transl. Med. 10, 0944 (2018).
Jahn, I. et al. Surface-enhanced Raman spectroscopy and microfluidic platforms: challenges, solutions and potential applications. Analyst 142, 1022–1047 (2017).
Veettil, T. C. P. et al. Disposable coverslip for rapid throughput screening of malaria using attenuated total reflection spectroscopy. Appl. Spectrosc. 76, 451–461 (2022).
Adegoke, J. A., Kochan, K., Heraud, P. & Wood, B. R. A near-infrared “matchbox size” spectrometer to detect and quantify malaria parasitemia. Anal. Chem. 93, 5451–5458 (2021).
Adegoke, J. A. et al. Ultraviolet/visible and near-infrared dual spectroscopic method for detection and quantification of low-level malaria parasitemia in whole blood. Anal. Chem. 93, 13302–13310 (2021).
Adegoke, J. A., Raper, H., Gassner, C., Heraud, P. & Wood, B. R. Visible microspectrophotometry coupled with machine learning to discriminate the erythrocytic life cycle stages of p. falciparum malaria parasites in functional single cells. Analyst 147, 2662–2670 (2022).
Rajaraman, S. et al. Pre-trained convolutional neural networks as feature extractors toward improved malaria parasite detection in thin blood smear images. PeerJ 6, 4568 (2018).
Umer, M. et al. A novel stacked cnn for malarial parasite detection in thin blood smear images. IEEE Access 8, 93782–93792 (2020).
Diker, A. An efficient model of residual based convolutional neural network with Bayesian optimization for the classification of malarial cell images. Comput. Biol. Med. 148, 105635 (2022).
Sahlol, A. T., Kollmannsberger, P. & Ewees, A. A. Efficient classification of white blood cell leukemia with improved swarm optimization of deep features. Sci. Rep. 10, 2536 (2020).
Cınar, A. & Tuncer, S. A. Classification of lymphocytes, monocytes, eosinophils, and neutrophils on white blood cells using hybrid alexnetgooglenet-svm. SN Appl. Sci. 3, 1–11 (2021).
Zhang, K. et al. Machine learning-reinforced noninvasive biosensors for healthcare. Adv. Healthc. Mater. 10, 2100734 (2021).
Cui, F., Yue, Y., Zhang, Y., Zhang, Z. & Zhou, H. S. Advancing biosensors with machine learning. ACS Sens. 5, 3346–3364 (2020).
Ralbovsky, N. M. & Lednev, I. K. Towards development of a novel universal medical diagnostic method: Raman spectroscopy and machine learning. Chem. Soc. Rev. 49, 7428–7453 (2020).
Tong, D. et al. Application of Raman spectroscopy in the detection of hepatitis b virus infection. Photodiagn. Photodyn. Ther. 28, 248–252 (2019).
Naseer, K., Amin, A., Saleem, M. & Qazi, J. Raman spectroscopy based differentiation of typhoid and dengue fever in infected human sera. Spectrochim. Acta Part A 206, 197–201 (2019).
Patel, S. K. et al. Rapid discrimination of malaria-and dengue-infected patients sera using Raman spectroscopy. Anal. Chem. 91, 7054–7062 (2019).
Goulart, A. C. C. et al. Diagnosing covid-19 in human serum using Raman spectroscopy. Lasers Med. Sci. 37, 2217–2226 (2022).
Nogueira, M. S. et al. Rapid diagnosis of COVID-19 using ft-ir atr spectroscopy and machine learning. Sci. Rep. 11, 1–13 (2021).
Wood, B. R. et al. Infrared based saliva screening test for COVID-19. Angew. Chem. 133, 17239–17244 (2021).
Chatzidrosos, G. et al. Miniature cavity-enhanced diamond magnetometer. Phys. Rev. Appl. 8, 044019 (2017).
Webb, J. L. et al. Nanotesla sensitivity magnetic field sensing using a compact diamond nitrogen-vacancy magnetometer. Appl. Phys. Lett. 114, 231103 (2019).
St¨urner, F. M. et al. Compact integrated magnetometer based on nitrogenvacancy centres in diamond. Diam. Relat. Mater. 93, 59–65 (2019).
St¨urner, F. M. et al. Integrated and portable magnetometer based on nitrogen-vacancy ensembles in diamond. Adv. Quantum Technol. 4, 2000111 (2021).
Burnett, J. L., Carns, J. L. & Richards-Kortum, R. Towards a needle-free diagnosis of malaria: in vivo identification and classification of red and white blood cells containing haemozoin. Malar. J. 16, 1–12 (2017).
Aydin-Schmidt, B. et al. Usefulness of Plasmodium falciparum-specific rapid diagnostic tests for assessment of parasite clearance and detection of recurrent infections after artemisinin-based combination therapy. Malar. J. 12, 1–11 (2013).
Serebrennikova, Y. M., Patel, J. & Garcia-Rubio, L. H. Interpretation of the ultraviolet-visible spectra of malaria parasite Plasmodium falciparum. Appl. Opt. 49, 180–188 (2010).
Chaorattanakawee, S. et al. Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (hrp-2 elisa) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia. Malar. J. 12, 1–11 (2013).
Bacon, D. J. et al. Comparison of a SYBR green I-based assay with a histidine-rich protein ii enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. Antimicrob. Agents Chemother. 51, 1172–1178 (2007).
Organization, W. H. et al. In vitro micro-test (mark iii) for the assessment of the response of plasmodium falciparum to chloroquine, mefloquine, quinine, amodiaquine, sulfadoxine. Technical report, World Health Organization (2001).
Webster, G. T., Tilley, L., Deed, S., McNaughton, D. & Wood, B. R. Resonance Raman spectroscopy can detect structural changes in haemozoin (malaria pigment) following incubation with chloroquine in infected erythrocytes. FEBS Lett. 582, 1087–1092 (2008).
Wood, B. R. et al. Tip-enhanced Raman scattering (ters) from hemozoin crystals within a sectioned erythrocyte. Nano Lett. 11, 1868–1873 (2011).
Kozicki, M. et al. An attenuated total reflection (atr) and Raman spectroscopic investigation into the effects of chloroquine on Plasmodium falciparum-infected red blood cells. Analyst 140, 2236–2246 (2015).
Serebrennikova, Y. M. et al. Spectrophotometric detection of susceptibility to anti-malarial drugs. Malar. J. 12, 1–9 (2013).
Rebelo, M. et al. A novel flow cytometric hemozoin detection assay for real-time sensitivity testing of Plasmodium falciparum. PloS ONE 8, 61606 (2013).
Acknowledgements
W.K.P. acknowledges the Frontier Research Grant of Songshan Lake Materials Laboratory and NSFC International Excellent Young Scientists (T2350610282). V.P.B. acknowledges the financial support from DST QUEST grant DST/ICPS/QuST/Theme-2/Q35 and the Institute of Eminence scheme at IIT-Madras, through the Quantum Center of Excellence for Diamond and Emergent Materials (QuCenDiEM) group. H.H. acknowledges the EPSRC Impact Acceleration Account (IAA) under grant EP/R511705/1, MAGNOSTIC: Novel non-Invasive Magnetic-based Malaria Diagnostic Sensor.
Author information
Authors and Affiliations
Contributions
W.K.P. and A.R. initiated the idea and prepared the first draft. All authors wrote and commented on the paper.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rathi, A., Chowdhry, Z., Patel, A. et al. Hemozoin in malaria eradication—from material science, technology to field test. NPG Asia Mater 15, 70 (2023). https://doi.org/10.1038/s41427-023-00516-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41427-023-00516-6
This article is cited by
-
Biomimetic Synthesis of the Plasmodium falciparum Malaria Pigment and Engineering of its Physical Attributes via pH Control
Biomedical Materials & Devices (2024)
-
Urinary liver-type fatty acid–binding protein level as a prognostic indicator of acute kidney injury secondary to severe falciparum malaria
CEN Case Reports (2024)